Long-term API stockpiling and rapid finished dose form manufacture

HaDEA (EU4Health) has published a pre-commercial procurement tender (HADEA/2026/OP/0021) to fund a 36-month pilot feasibility project on long-term stockpiling of Active Pharmaceutical Ingredients (APIs) and rapid manufacture of finished dose forms. The estimated contract value is €6,000,000 and tenders must be submitted electronically via the EU Funding & Tenders Portal. The project scope includes API stabilization and shelf-life extension technologies, stability studies, rapid conversion workflows to finished dose forms, regulatory and GMP considerations, and operational recommendations for crisis preparedness. Eligible bidders include pharmaceutical manufacturers, API suppliers, CDMOs, research organisations and consortia meeting the tender selection criteria, with submission deadline 29 September 2026 (15:00:59 CET).

Tender summary

Essential information

HaDEA is procuring a feasibility pilot to assess technologies and operational approaches for prolonged bulk API stockpiling and rapid conversion to finished dose forms to strengthen crisis preparedness, sustainability and resilience.

Estimated value:The procurement is estimated at €6 000 000 overall and is a services contract for an expected 36-month period ¹.

1. 1What it funds: a pilot feasibility project to test long-term bulk API storage approaches and rapid finished-dose manufacturing from bulk APIs.
2. 2Who can apply: bidders eligible under EU public procurement rules — typically legal entities or consortia with relevant pharmaceutical, manufacturing and regulatory expertise (see tender documents).
3. 3Key dates: submission deadline 29 September 2026 (submission by eSubmission).

Full tender documents (invitation, specifications, draft contract and financial forms) are published on the EU Funding & Tenders Portal and should be consulted for eligibility, selection and award criteria and detailed requirements Tender details. ¹

Footnotes

1. 1Tender package published 24 June 2026 includes Invitation to tender, Tender Specifications, Draft Direct Service Contract and Financial Offer Form available from the portal link above.

Summary

The European Health and Digital Executive Agency (HaDEA) will award a services contract to develop and run a pilot feasibility project to assess the concept of long-term stockpiling of Active Pharmaceutical Ingredients (APIs) in bulk combined with advanced manufacturing technologies to rapidly produce finished dose forms from those bulk APIs. The project aims to evaluate viability, sustainability, resiliency, shelf-life extension technologies for APIs in bulk, rapid finished-dose manufacturing approaches, and provide operational recommendations for crisis preparedness and future health emergency response. The procurement is managed through the EU Funding & Tenders Portal under Call Identifier HADEA/2026/OP/0021. The estimated overall contract value is €6,000,000 and the planned maximum duration is 36 months.

Key dates and administrative facts

Publication date on portal:24 June 2026. Tender submission deadline: 29 September 2026, 15:00:59 (Brussels time). Open tender event: 30 September 2026 at 10:00 (Brussels time). Additional information request period ends: 21 September 2026. Documents were published on 24 June 2026 and include invitation to tender, draft direct service contract, tender specifications, draft contract annex on security requirements, financial offer form and a declaration on honour. Submission method: eSubmission via the Funding & Tenders Portal. Estimated total procedure value: €6,000,000. Procurement nature: services (CPV main code 73100000).

Reference documents available:Invitation to tender; Draft Direct Service Contract; Appendix 1 Security requirements; Tender Specifications; Financial Offer Form (Excel); Declaration on Honour. Full tender package available via the EU Funding & Tenders Portal Funding & Tenders Portal - Tender details ¹.

Eligibility and applicant requirements

The procurement is run by HaDEA. The tender documentation contains the precise selection and exclusion criteria, professional and technical capacity requirements and any required supporting evidence. Tenderers must complete the Declaration on Honour and the Financial Offer Form. Security requirements are specified in the contract annex. Tender validity is indicated as 6 months in the tendering terms. SMEs suitability indicator in the procurement record is false (procurement not specifically reserved to SMEs).

1. 1Eligible Applicant Types: The tender is open to legal entities meeting the procurement selection criteria specified in the tender documents. Typical eligible types include private sector companies (including SMEs and large enterprises), research organisations, universities, research institutes, not-for-profits and consortia of such entities, provided they satisfy the selection and exclusion criteria included in the procurement documents. Natural persons/individuals are not indicated as primary suppliers for this services procurement.
2. 2Funding Type: This is a public procurement for a services contract (direct service contract) awarded by HaDEA. The financial mechanism is a procurement contract (service contract) that results in payment for services delivered rather than a grant.
3. 3Consortium Requirement: The tender allows for single tenderers or economic operators acting as a consortium/consortium-like structure (joint bids) if permitted by the tender specifications. The procurement documents include requirements under tenderer qualification; bidders should consult the tender specifications for details on whether joint tenders or subcontracting are allowed and how to present capacity of members.
4. 4Beneficiary Scope (Geographic Eligibility): The contracting authority is a European Union agency (HaDEA). The tender is published on the EU portal; legal entities established in EU Member States are eligible. The tender documents should be consulted for the full list of eligible countries (commonly EU, EEA and potentially third countries if specified).
5. 5Target Sector: Health and pharmaceutical manufacturing, supply chain resilience, advanced manufacturing technologies, pharmaceutical R&D, crisis preparedness and public health emergency response.
6. 6Project Stage: Feasibility and pilot. The procurement calls for a feasibility project and a pilot to test concepts (research/assessment, development of pilot activities, demonstration of operational models and recommendations for operationalisation).
7. 7Funding Amount: Estimated overall contract amount and estimated total procedure value: €6,000,000 (six million euros). This represents the budget envelope for the contract award.
8. 8Application Type: Open tender published on the Funding & Tenders Portal. Submission method is eSubmission through the Portal and bidders must follow the portal submission procedures.
9. 9Nature of Support: Financial payment for services (contractual remuneration). Awarded contractor will receive monetary compensation under the terms of the service contract for delivering the feasibility pilot and deliverables.
10. 10Application Stages: The procurement follows a single-stage submission process (submit tender via eSubmission by the deadline). There is an open tender event and an additional information period; the award procedure is a procurement evaluation (quality and price) rather than a multi-stage grant selection. The awarding criteria are quality (80 weight) and price (20 weight) as indicated in the tendering terms, however bidders must consult the tender specifications for the detailed scoring and evaluation methodology.
11. 11Success Rates: Not stated. As with public tenders, success rate depends on number and quality of bids; no maximum number of awards indicated (single contract for this procurement).
12. 12Co-funding Requirement: Not applicable in the sense of grant co-financing. This is a procurement: the contractor will be paid according to the contract. No co-funding by the bidder is required unless specified as part of the commercial offer or financial commitments in the tender documentation.
13. 13Templates and Application Forms: The procurement package includes a Financial Offer Form (Excel), Declaration on Honour (docx), Tender Specifications (PDF), Draft Direct Service Contract (PDF), and appendix on security requirements. Bidders must complete the Financial Offer Form and Declaration on Honour and attach required evidence for selection criteria as detailed in the tender specifications.

Technical scope and expected outputs

Expected deliverables:pilot feasibility study reports, technical assessments of shelf-life extension technologies for APIs, demonstration of rapid finished dose manufacturing workflows or prototypes, risk and legal/regulatory assessment (including GMP/regulatory compliance considerations), cost and sustainability analysis, operational implementation recommendations and a roadmap for operationalisation and scale-up in crisis scenarios.

1. 1Science and technology focus areas (examples of expected technical content): characterization of API degradation pathways; stabilization technologies for bulk APIs (e.g., controlled atmospheres, desiccation, cryostabilization, lyophilisation in bulk if relevant); analytical methods for monitoring long-term API stability; modular and continuous manufacturing technologies for converting APIs into tablets, capsules, sterile injectables or other dose forms rapidly; process development, quality assurance, validation approaches for on-demand manufacturing; supply chain and logistics modelling; environmental and sustainability impact assessment.
2. 2Regulatory and compliance areas: Good Manufacturing Practice (GMP) implications for bulk API stockpiling and rapid manufacture of finished dose forms; regulatory pathways for emergency use; quality control sampling schemes adapted to long-term bulk storage and rapid production; labelling and traceability.

Awarding and evaluation

Award criteria and weighting:The tendering terms indicate two main awarding criteria: quality (weight 80) and price (weight 20). Bidders must consult the Tender Specifications for detailed sub-criteria, scoring grids, minimum thresholds, technical and financial evaluation methodology and instructions on how to compile and present proposals and evidence for compliance with selection criteria.

Tender evaluation process:The contract will be awarded following evaluation of submitted tenders against the published quality and price criteria. The contracting authority specifies standard procurement selection and exclusion checks; bidders must provide required administrative, legal and financial documentation as requested in the tendering documents.

Procurement mechanics and practical guidance

Submission:Electronic submission only through the Funding & Tenders Portal (eSubmission). Bidders must ensure timely submission before the stated deadline. Use the provided Financial Offer Form and Declaration on Honour and include all requested technical annexes and supporting evidence. Check the tender specifications for language requirements, required formats, and any page limits or template structures. The tender validity period is specified as 6 months and must be respected.

1. 1Recommended consortium composition: For multidisciplinary feasibility projects, include expertise in analytical chemistry/pharmaceutical stability, manufacturing engineering (continuous and modular manufacturing), regulatory affairs (GMP and emergency regulatory pathways), supply chain modelling, and project management. If a consortium bid is submitted, ensure clear legal arrangements, lead beneficiary, responsibility matrix and evidence of member capacities are provided.
2. 2Key annexes to prepare: technical proposal describing pilot design and methodology, work plan, milestones, deliverables and Gantt chart; detailed CVs and evidence of relevant past experience; quality assurance plan and regulatory compliance approach; financial offer completed in the provided form; declaration on honour and legal and financial capacity documents.

Mentioned countries and geographic scope

The published tender is issued by an EU agency (HaDEA) and is published on the EU Funding & Tenders Portal. The opportunity text itself does not list specific countries; the geographic eligibility defaults to the rules specified in the tender specifications. In typical HaDEA procurements, eligible tenderers are organisations established in EU Member States and may include entities from EEA or other countries if explicitly permitted in the procurement documents. Bidders must check the tender specifications for the definitive list of eligible countries.

Unanswered or unspecified items (as published)

Success rate:Not provided. Exact list of eligible countries: to be confirmed in tender specifications. Whether consortium structure is mandatory or optional: tender documents to be consulted; selection criteria and instructions for joint bids will clarify. Precise minimum technical threshold scores, detailed sub-criteria descriptions and timetable for award decision will be in the Tender Specifications and Draft Contract included in the portal documents.

Templates and how the application forms look

The procurement package published on the portal includes the following templates and forms that bidders must use or reference when preparing a submission:

1. 1Invitation to tender (PDF): explains the procurement procedure, summary of requirements and instructions for bidders.
2. 2Draft Direct Service Contract (PDF): contains the proposed contract terms, obligations, payment modalities, deliverables, intellectual property, confidentiality, liability and termination clauses. Bidders should review and indicate acceptance or comment as allowed by the tendering rules.
3. 3Appendix 1 Security requirements (PDF): defines security classifications, handling of sensitive information and any special security clearances or measures required for contract execution.
4. 4Tender Specifications (PDF): the core technical and administrative requirements, selection and award criteria, scoring methodology, list of deliverables and reporting requirements. This document defines the technical scope and must be followed precisely.
5. 5Financial Offer Form (Excel native): structured cost template where bidders complete price breakdowns, totals and any required cost justifications. Use this exact form for price submission.
6. 6Declaration on Honour (DOCX): administrative self-declaration of non-exclusion, absence of conflicts, and other declarations required under EU procurement rules.

Bidders must follow the formats, complete required templates and include supporting documentation as requested in the Tender Specifications. Failure to use the prescribed templates or to supply required declarations and evidence can lead to exclusion or rejection of the tender.

Final summary and advice

This HaDEA procurement aims to commission a comprehensive pilot feasibility project to explore a strategic public-health preparedness concept: long-term stockpiling of bulk APIs with the capacity for rapid conversion into finished dose forms through flexible, advanced manufacturing. The awarded contractor will perform technical assessments, pilot demonstrations, regulatory and operational analyses, sustainability and resilience appraisals, and produce concrete recommendations and an operational roadmap to enable the EU and Member States to operationalise API stockpiling and rapid manufacture strategies for future health emergencies.

Practical next steps for interested bidders:download and study all tender documents on the Funding & Tenders Portal; assemble a multidisciplinary team combining pharmaceutical stability and analytical experts, manufacturing engineers with modular/continuous/on-demand production experience, regulatory affairs specialists, supply chain and logistics modellers and project managers; complete and submit the Financial Offer Form and Declaration on Honour via eSubmission before the deadline; ensure compliance with security and contractual requirements in the draft contract annexes; and use the additional information period to raise clarifying questions through the portal before the cut-off date.

This opportunity is a procurement (service contract) with a total estimated value of €6,000,000 intended to finance a 36-month feasibility and pilot project addressing API shelf-life extension and rapid finished-dose manufacturing for crisis preparedness. Interested parties should prepare compliant, high-quality technical proposals focused on demonstrable technical expertise, realistic pilot plans, regulatory-compliant production concepts and clear cost proposals aligned with the Financial Offer Form.

For access to the full tender dossier and submission portal, consult the Funding & Tenders Portal tender page for HADEA/2026/OP/0021 Tender details ¹.

Footnotes

1. 1Tender package published on 24 June 2026 on the EU Funding & Tenders Portal: Invitation to tender; Draft Direct Service Contract; Appendix 1 Security requirements; Tender Specifications; Financial Offer Form; Declaration on Honour. Access via the portal tender details page linked above.

Opportunity Overview

This is a pre-commercial procurement (PCP) tender under the EU4Health programme, managed by the European Health and Digital Executive Agency (HaDEA), to develop a pilot feasibility project for long-term stockpiling of Active Pharmaceutical Ingredients (APIs) and rapid manufacturing of finished dose forms to enhance crisis preparedness ¹.

The project aims to test technologies that prolong the shelf-life of bulk APIs and enable rapid conversion into finished pharmaceutical products during health emergencies, focusing on sustainability, resiliency, and flexibility ².

Indicative Budget:The estimated overall contract amount is €6,000,000, covering a duration of 36 months ³.

Key Deadlines and Timeline

1. 1Contract Notice Publication: Expected May 2026
2. 2Submission Deadline 1: 01 January 2026 at 13:00:59 CET (Note: This date appears to be a placeholder or error in the metadata; the primary deadline is likely the later date)
3. 3Primary Submission Deadline: 29 September 2026 at 15:00:59 CET
4. 4Project Duration: 36 months from contract signature

Who Should Apply

The tender is suitable for economic operators with expertise in pharmaceutical manufacturing, specifically API suppliers, Chemical, Pharmaceutical, Chiral, and Biotechnological (CDMO) companies, and firms capable of rapid formulation and stability testing ⁴.

Interested parties include companies that can develop rapid manufacturing processes for finished dose forms and conduct stability studies to demonstrate the feasibility of long-term API storage ¹.

Scope and Technical Requirements

Award Criteria

The awarding criteria are weighted as follows:Quality accounts for 80% and Price accounts for 20% of the total evaluation score ⁵.

Tenderers must consult the official procurement documents (Tender Specifications and Draft Contract) for detailed technical and quality requirements ⁵.

Application Process and Documents

Tenders must be submitted electronically via the EU Funding and Tenders Portal using the ESUBMISSION method ⁶.

Key documents available for review include the Invitation to Tender, Draft Direct Service Contract, Tender Specifications, Security Requirements Appendix, Declaration on Honour, and Financial Offer Form ⁶.

Strategic Context

This initiative aligns with the EU4Health programme's objective to improve the availability and accessibility of critical medicines and enhance crisis preparedness for future health emergencies ⁷.

Stockpiling APIs is strategically advantageous as they are generally lower-cost and have longer shelf lives than finished drug products, a concept also recognized in global supply chain resilience strategies ⁸.

Footnotes

1. 1Prior Information Notice: Long-term stockpiling of active pharmaceutical ingredients (APIs) and rapid production of finished dose forms, HaDEA, 1 April 2026 HaDEA PIN.
2. 2Call for tenders: Long-term API stockpiling and rapid finished dose form manufacture, EU Funding & Tenders Portal Portal Link.
3. 3Call for tenders launched by Directorate-General for Health Emergency Preparedness and Response Authority, NCP Brussels NCP Brussels.
4. 4Finished Dosage Forms vs. APIs - Upperton Pharma Solutions Upperton.
5. 5Procurement Project Lots details, EU Funding & Tenders Portal Portal Lots.
6. 6Cft Documents list, EU Funding & Tenders Portal Portal Docs.
7. 7Europe Tests API Stockpiling for Medicine Resilience, LinkedIn LinkedIn.
8. 8Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve, White House White House.